Home > Specialists > Urology > Dr. Jiwei Huang (黄吉炜)
Specialty & Clinical Focus:
Urologic oncology specialist at Renji Hospital in Shanghai, with a clinical focus on kidney, renal pelvis, ureteral and adrenal tumors, as well as advanced robotic, laparoscopic and kidney-sparing surgery.
Professional Title & Qualifications:
-
Chief Physician
Hospital & Department：
Shanghai Renji Hospital, Jiao Tong University – Department of Urology
(address: No. 160 Pujian Road, Pudong New Area, Shanghai, 200127)
Dr. Jiwei Huang (黄吉炜) - Urologist
Personal Biography
Dr. Jiwei Huang is a Chief Physician, Master’s Supervisor and Director of the Second Urology Ward at the West Campus of Shanghai Renji Hospital. He has worked in urologic oncology for more than a decade, focusing on kidney cancer, renal pelvis and ureteral cancer, adrenal tumors, and complex robotic and laparoscopic surgery.
He earned a Ph.D. in Surgery from Peking Union Medical College and completed postdoctoral training in urologic oncology and kidney-tumor research at Massachusetts General Hospital, Harvard Medical School. His clinical work includes kidney-sparing procedures, lymph-node dissection and surgery for kidney cancer with inferior vena cava thrombus. He has also presented surgical techniques and treatment approaches at international urology conferences including the EAU, AUA and UAA.
Why Choose Dr. Jiwei Huang for Your Urological Care?
Dr. Huang combines senior clinical leadership at Shanghai Renji Hospital with doctoral training at Peking Union Medical College and postdoctoral research at Massachusetts General Hospital, Harvard Medical School. His practice centers on urologic oncology, particularly kidney, renal pelvis, ureteral and adrenal tumors, including anatomically complex cases that may require robotic, laparoscopic or kidney-sparing approaches.
For international patients, his experience is particularly relevant when reviewing how a proposed surgical approach relates to the diagnosis, imaging findings and previous treatment history. A well-prepared remote specialist review can help patients organize their scans, pathology reports, medical history and priority questions before deciding whether to pursue care in Shanghai. Dr. Huang’s experience with complex renal and upper urinary tract tumors, together with his participation in urothelial carcinoma guideline writing, supports a structured, evidence-informed discussion of the available clinical options.
Pre-Travel Case Review & Specialist Liaison
Before committing to medical travel to China, international patients can request MedBridgeNZ coordination for a pre-travel remote specialist review with Dr. Huang. We organize medical-record preparation, translation coordination, client-authorized document transfer and appointment communication with the relevant specialist office.
Once the remote review request is accepted and scheduled, Dr. Huang will review the submitted records, provide a specialist opinion and recommendations, and address the patient’s questions. This can help clarify the proposed care pathway and whether an in-person visit to Shanghai should be considered before major travel arrangements are made.
After the specialist review, MedBridgeNZ can coordinate hospital appointment requests, medical invitation or visa-document support, travel planning and on-the-ground logistics where required.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Jiwei Huang
Areas of Expertise
Urologic oncology, particularly kidney tumors, renal pelvis tumors, ureteral tumors, and adrenal tumors.
Comprehensive treatment and various robotic and laparoscopic urological surgeries.
Zero-ischemia microwave ablation and enucleation for renal tumors.
Kidney-sparing laser surgery for renal pelvis and ureteral cancer.
Surgery for kidney cancer with inferior vena cava thrombus.
Robotic and laparoscopic partial nephrectomy.
Laparoscopic radical nephrectomy.
Robotic and laparoscopic adrenalectomy.
Laparoscopic radical nephroureterectomy + standard lymph node dissection.
Robotic and laparoscopic segmental ureterectomy.
Retroperitoneal lymph node dissection for testicular tumors.
Radical prostatectomy and radical cystectomy.
Neoadjuvant/adjuvant therapy for renal pelvic, ureteral, and kidney cancer.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
20,000 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Director, Second Urology Ward (West Campus): Renji Hospital, Shanghai Jiao Tong University School of Medicine
Postdoctoral Fellow (Feb 2014 - Feb 2015): Department of Urology, Massachusetts General Hospital, Harvard Medical School, USA
Attending Physician / Chief Physician: Department of Urology, Renji Hospital (worked in urologic oncology for over a decade post-graduation)
Education & Training
Postdoctoral Fellowship: Department of Urology, Massachusetts General Hospital, Harvard Medical School
Ph.D. (Surgery): Peking Union Medical College (Tsinghua University Medical School)
Visiting Scholar (Feb 2014 - Feb 2015): Department of Urology, Massachusetts General Hospital, Harvard Medical School
Awards & Honors
2013: Outstanding Teaching Individual, Renji Hospital
2015: First Prize, Shanghai Medical Science and Technology Progress Award
2016: Second Prize, Huaxia Science and Technology Progress Award
2016: First Prize, Ministry of Education Science and Technology Progress Award
2016: Best Poster Award, European Association of Urology (EAU) Annual Meeting
2017: Second Place (National), CARS Almighty Doctor Surgical Competition (for laparoscopic partial nephrectomy of completely endophytic renal sinus tumors)
2018: First Place (National), Upper Tract Urothelial Carcinoma Group, Surgical Video Competition, Chinese Urological Association Annual Meeting
2020: Second Place (National), First National Urological Robotic Surgery Competition, Chinese Medical Association
2020: Excellence Award, National Young and Middle-aged Urologists Clinical Research Skills Competition
Academic & Professional Memberships
Member, Chinese Medical Association
Member, Minimally Invasive Surgery Group, Youth Committee of Chinese Medical Association
Member, Urothelial Carcinoma Expert Committee, Chinese Society of Clinical Oncology (CSCO)
Secretary, China Upper Tract Urothelial Carcinoma (UTUC) Alliance
Member, Renal Cancer Collaborative Group, Chinese Medical Doctor Association
Expert, Guideline Writing Committee for Upper Tract Urothelial Carcinoma, Chinese Medical Association
Writing Expert, CSCO Urothelial Carcinoma Guidelines
Corresponding Editor, Chinese Journal of Oncology
Member, Youth Editorial Board, JCO Chinese Edition
Research & Publications
Principal investigator for one National Natural Science Foundation of China (NSFC) youth project related to kidney cancer, and several other projects.
Published over 30 papers in international English SCI journals as first or corresponding author.
Published over 10 papers in domestic core journals.
Selected Peer-Reviewed Publications
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial.
Huang J et al.
J Immunother Cancer. 2024;12(6):e008475.
PMID: 38862251A Phase 2 Study of Tislelizumab as Neoadjuvant Treatment of Cisplatin-Ineligible High-Risk Upper Tract Urothelial Carcinoma.
Huang J et al.
J Urol. 2025;213(6):739–752.
PMID: 39999445Prospective Clinical Trial of the Oncologic Outcomes and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Huang J et al.
Front Oncol. 2022;12:791140.
PMID: 35280720
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Q: Does Dr. Huang’s clinical focus match my urological condition?
Dr. Huang’s clinical focus includes urologic oncology involving kidney, renal pelvis, ureteral and adrenal tumors, together with robotic, laparoscopic and kidney-sparing procedures. Suitability cannot be determined from a short enquiry alone. MedBridgeNZ can coordinate preparation, translation and client-authorized transfer of your imaging, pathology, reports, treatment history and questions. Once a remote specialist-review request is accepted and scheduled, Dr. Huang will review the submitted records, provide his opinion and recommendations, and address the questions relevant to your case before you decide whether to pursue care in Shanghai.
Q: How can I request a remote specialist review or hospital appointment from overseas?
Contact MedBridgeNZ with a brief case summary and the available medical records. We will coordinate document organization, translation where needed, secure client-authorized transfer and appointment communication with the relevant Renji Hospital specialist office. Once the remote review is confirmed, Dr. Huang will review the records and respond through the arranged pathway. If an in-person visit is then considered, MedBridgeNZ can assist with an appointment request and the administrative steps for a hospital visit in Shanghai. Appointment timing remains subject to the specialist office and hospital schedule.
Q: What support is available if I travel to Shanghai for treatment?
If you decide to travel after the specialist review, MedBridgeNZ can coordinate the non-clinical parts of the journey, including appointment communication, medical invitation or visa-document support, accommodation and ground-transport planning, and non-clinical bilingual administrative support for hospital visits. The Renji Hospital team remains responsible for examinations, diagnosis, treatment planning and clinical care. We organize the logistics around the hospital pathway so that records, schedules and practical arrangements are prepared in advance and any changes can be communicated clearly during the trip.
Q: How will I communicate with Dr. Huang and Renji Hospital if I do not speak Chinese?
MedBridgeNZ can coordinate professional translation for medical records and arrange non-clinical bilingual administrative support for remote and in-person appointments. The support person can assist with registration, appointment navigation, document exchange and communication logistics, while the specialist explains the clinical findings, options and recommendations. Before each appointment, we can also help organize a bilingual question list and confirm that the relevant reports have been submitted to the hospital team. This helps reduce avoidable communication gaps and provides a clearer record of the specialist’s responses.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We coordinate appointment requests, medical-record preparation, translation, client-authorized document transfer, medical invitation or visa-document support, travel planning and non-clinical bilingual administrative assistance. MedBridgeNZ does not provide medical advice, diagnosis or treatment; all clinical opinions and care decisions come from the relevant licensed specialist or hospital. Hospital, specialist and other third-party costs remain separate unless expressly confirmed in writing.